SAN FRANCISCO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, today announced that management will participate in multiple upcoming healthcare conferences being held in February and March.
Guggenheim SMID Cap Biotech Conference
| Format: | Fireside chat and 1x1 meetings | |
| Date/time: | Wednesday, February 5 at 10:30 a.m. ET | |
| Location: | New York, NY | |
| Webcast link: | https://wsw.com/webcast/guggen2/gpcr/2003892 | |
| Format: | Fireside chat and 1x1 meetings | |
| Date/time: | Monday, March 10 at 1:00 p.m. ET | |
| Location: | Miami, FL | |
| Webcast link: | https://wsw.com/webcast/leerink38/gpcr/2218364 | |
| Format: | 1x1 meetings | |
| Date: | Tuesday, March 11 | |
| Location: | Miami, FL | |
About Structure Therapeutics
Structure Therapeutics is a science-driven clinical-stage biopharmaceutical company focused on discovering and developing innovative oral small molecule treatments for chronic metabolic and cardiopulmonary conditions with significant unmet medical needs. Utilizing its next generation structure-based drug discovery platform, Structure Therapeutics has established a robust GPCR-targeted pipeline, featuring multiple wholly-owned proprietary clinical-stage small molecule compounds designed to surpass the scalability limitations of traditional biologic and peptide therapies and be accessible to more patients around the world. For additional information, please visit www.structuretx.com.
Investors:
Danielle Keatley
Structure Therapeutics Inc.
Media:
Dan Budwick
1AB
